Li’s research will investigate the link between maternal immune activation during fetal development and the development of neurological disorders.
Category: Grant
Timothy Holy awarded R01 grant to investigate mouse pheromones
The project aims to answer a fundamental question in neuroscience: how do olfactory cues direct behavior?
ICTS pilot funding drives research on neurodegenerative diseases (Links to an external site)
The Zhao Lab is grateful for ICTS, GTAC@MGI, Knight ADRC, and the Movement Disorders Center for their generous support.
Geoffrey Goodhill receives grant to monitor every neuron in the brain during sleep and wake
In collaboration with labs from Caltech and the University of Southern California, his team will track each cell in the zebrafish brain to document the biological basis of sleep.
Guoyan Zhao receives grant for single-cell proteomics in the human brain
Zhao, an assistant professor in the Department of Neuroscience, will apply imaging mass cytometry technology to analyze tissue samples from Alzheimer’s patients.
Yao Chen, PhD, receives grant from Mathers Foundation
The $500,000 award will go toward studying cellular influences on neuromodulator function.
Guoyan Zhao receives grant to investigate genetic variations in neurodegenerative diseases
The $7 million grant awarded to a team of collaborators is part of the NIH’s new Impact of Genomic Variation on Function Consortium.
Michael Nonet receives R01 grant to improve transgenesis method
The project aims to refine recombination-mediated cassette exchange (RMCE), an approach to inserting large DNA sequences into the genome, for use in the model organism C. elegans.
Linda Richards receives Pioneer Award from NIH (Links to an external site)
Richards, the head of the Department of Neuroscience, will apply the high-risk, high-reward grant to developing a new animal model for studying brain development.
Ilya Monosov receives grant to develop noninvasive treatment method (Links to an external site)
Along with co-PI Hong Chen, associate professor of biomedical engineering, and collaborators including neuroscience professor Larry Snyder, Monosov will adapt an approach to controlling brain activity, called optogenetics, with the ultimate goal of repairing neural dysfunction.